Join Growin Stock Community!

Enovis corporationENOV.US Overview

US StockIndustrials
(No presentation for ENOV)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

ENOV AI Insights

ENOV Overall Performance

ENOV AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

ENOV Recent Performance

-1.65%

Enovis corporation

0.28%

Avg of Sector

-0.31%

S&P500

ENOV PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

ENOV Key Information

ENOV Financial Forecast

chart

Browsing restrictions can be lifted for a fee.

QuarterlyEPS ForecastQoQMaxMin
2026Q1
2026Q2
2026Q3
2026Q4
2027Q1

ENOV Profile

Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports related injuries. It offers rigid and soft orthopedic bracings, hot and cold therapy products, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators used for pain management, and physical therapy products; and a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger. Enovis Corporation sells its products through independent distributors, such as healthcare professionals, consumer retail stores, and pharmacies; and directly under the DJO brand. The company was formerly known as Colfax Corporation. Enovis Corporation is headquartered in Wilmington, Delaware.

Price of ENOV

ENOV FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

ENOV Earnings Table

Unit : USD

QTRNon-GAAP EPSEPS YoYEPS Surprise %SalesSales YoYSales Surprise %NPM
Current
2025Q4
2025Q3
2025Q2
2025Q1
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-20.71
PE Ratio (TTM)
-
Forward PE
6.87
PS Ratio (TTM)
0.65
PB Ratio
0.72
Price-to-FCF
71.93
METRIC
VALUE
vs. INDUSTRY
Gross Margin
59.84%
Net Margin
-52.69%
Revenue Growth (YoY)
6.66%
Profit Growth (YoY)
13.93%
3-Year Revenue Growth
12.10%
3-Year Profit Growth
14.67%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-20.71
PE Ratio (TTM)
-
Forward PE
6.87
PS Ratio (TTM)
0.65
PB Ratio
0.72
Price-to-FCF
71.93
Gross Margin
59.84%
Net Margin
-52.69%
Revenue Growth (YoY)
6.66%
Profit Growth (YoY)
13.93%
3-Year Revenue Growth
12.10%
3-Year Profit Growth
14.67%

  • When is ENOV's latest earnings report released?

    The most recent financial report for Enovis corporation (ENOV) covers the period of 2025Q4 and was published on 2025/12/31. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating ENOV's short-term business performance and financial health. For the latest updates on ENOV's earnings releases, visit this page regularly.

  • What is the operating profit of ENOV?

    According to the latest financial report, Enovis corporation (ENOV) reported an Operating Profit of -502.18M with an Operating Margin of -87.22% this period, representing a growth of 24.46% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.

  • How is ENOV's revenue growth?

    In the latest financial report, Enovis corporation (ENOV) announced revenue of 575.76M, with a Year-Over-Year growth rate of 2.64%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.

  • How much debt does ENOV have?

    As of the end of the reporting period, Enovis corporation (ENOV) had total debt of 1.35B, with a debt ratio of 0.35. Long-term debt comprises a higher/lower proportion. The level of financial leverage directly impacts the company's capital structure and interest coverage. If debt is high, pay attention to interest expenses and refinancing risks. Conversely, a low-leverage structure indicates greater risk tolerance but potentially less growth flexibility.

  • How much cash does ENOV have?

    At the end of the period, Enovis corporation (ENOV) held Total Cash and Cash Equivalents of 36.39M, accounting for 0.01 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does ENOV go with three margins increasing?

    In the latest report, Enovis corporation (ENOV) did not achieve the “three margins increasing” benchmark, with a gross margin of 60.7%%, operating margin of -87.22%%, and net margin of -90.4%%. This demonstrates limited improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess ENOV's profit trajectory and future growth potential.

  • Is ENOV's EPS continuing to grow?

    According to the past four quarterly reports, Enovis corporation (ENOV)'s earnings per share (EPS) shows a steady growth trend, with the latest EPS at -9.11. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.

  • What is the FCF of ENOV?

    Enovis corporation (ENOV)'s Free Cash Flow (FCF) for the period is 32.29M, calculated as Operating Cash Flow minus Capital Expenditures, representing a fall of 8.11% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.

  • What are the PEG ratio and PE ratio of ENOV?

    The latest valuation data shows Enovis corporation (ENOV) has a Price-To-Earnings (PE) ratio of -1.23 and a Price/Earnings-To-Growth (PEG) ratio of 0.08. A PEG below 1 usually suggests the market is underestimating growth potential, while a PEG above 1 indicates high growth expectations are already priced in. Investors should conduct a comprehensive valuation by considering historical growth, market forecasts, and industry cycles.